Health
Popular breast cancer drugs don’t work the way we thought they did: Study suggests changes in so-called PARP inhibitors could boost potency, efficacy – Science Daily
New research suggests that a class of drugs called PARP inhibitors, designed to treat hereditary forms of ovarian and breast cancer, don’t work the way we thought…
Some of the most commonly used drugs for treating hereditary breast and ovarian cancers may not work the way we thought they did, according to new University of Colorado Boulder research.The paper, published February 2 in the journal Nature Communications, sheds new light on how they do work and could open the door to new next-generation medications that work better, the authors said.
“Despite the success of these drugs which sell in the billions of dollars per year and treat many thousands of patients,…
-
General22 hours agoNew US tariffs on semiconductors coming ‘over the next week’, Donald Trump says
-
Noosa News23 hours agoAustralian Idol 2025 winner draws crowd for Noosa pop up show
-
Noosa News23 hours agoQantas sale aims to boost outback tourism after devastating Queensland floods
-
Noosa News23 hours agoBlood found in ensuite after police investigated ‘lawn mower accident’